International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
Clinica Universidad de Navarra · Memorial Sloan Kettering Cancer Center · +42 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
110
total citations
- FWCI
- 27.84
- Percentile
- 100%
- References
- 71
Citations per year
Authors
37- PRPaula Rodríguez‐OteroCorresponding
Clinica Universidad de Navarra
- SZSaad Z. Usmani
Memorial Sloan Kettering Cancer Center, Cornell University
- ADAdam D. Cohen
University of Pennsylvania
- NWNiels W.C.J. van de Donk
Amsterdam University Medical Centers, Vrije Universiteit Amsterdam
- XLXavier Leleu
Centre Hospitalier Universitaire de Poitiers
Topics & keywords
Topics
Keywords
- Medicine
- Multiple myeloma
- Chimeric antigen receptor
- Immunotherapy
- Clinical trial
- Oncology
- Antibody
- Antigen
No related works found for this paper.